Physician profile
James R Lachman
NPI 1841553278
$130,215.69
in general payments reported to CMS, 2019-2025
9 companies · $57K in 2025
The $57K reported for 2025 was more than what 91% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,192 · 2021: $1,975 · 2022: $9,046 · 2023: $8,918 · 2024: $50K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $88K · Royalty Or License: $13K · Travel and Lodging: $8,661 · Food and Beverage: $6,815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $87,828.64 |
| Royalty Or License | $12,697.85 |
| Travel and Lodging | $8,660.51 |
| Food and Beverage | $6,815.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exactech, INC. | $102,793.48 | 2021-2025 | |
| Stryker Corporation | $22,295.99 | 2019-2025 | Infinity, Prophecy, Invision |
| Arthrex, INC. | $2,014.75 | 2019 | |
| Advita Ortho, LLC | $1,960.00 | 2025 | |
| Wright Medical Technology, INC. | $480.00 | 2019 | |
| Medline Industries Lp | $399.92 | 2022-2023 | |
| Novus Surgical Consultants | $188.85 | 2022-2024 | |
| Paragon 28, INC. | $71.55 | 2021 | |
| Integra Lifesciences Corporation | $11.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lachman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.